Forte Biosciences is a biopharmaceutical company focused on autoimmune diseases. Forte’s lead product, FB-102, is a proprietary molecule for the treatment of autoimmune and autoimmune related diseases. Our initial focus will be on Graft-versus-Host Disease (GvHD), Vitiligo and Alopecia Areata, large indications with unmet needs. GvHD is a common potentially life-threatening complication commonly associated with allogeneic hematopoietic stem cell transplantation. Vitiligo is a chronic disorder that causes patches of skin to lose pigment or color. Alopecia Arcata is where patches of hair loss occur on the scalp or the body.